Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia

Published:2010-11-11 Issue:3 Volume:56 Page:361-367
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Egbelakin Akinbode,Ferguson Michael J.,MacGill Emily A.,Lehmann Amalia S.,Topletz Ariel R.,Quinney Sara K.,Li Lang,McCammack Kevin C.,Hall Stephen D.,Renbarger Jamie L.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22845/fullpdf

Reference30 articles.

1. Appropriateness of maximum-dose guidelines for vincristine;McCune;Am J Health Syst Pharm,1997

2. Vincristine pharmacokinetics after repetitive dosing in children;Gidding;Cancer Chemother Pharmacol,1999

3. The pharmacokinetics of vincristine in man: Reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination;Van den Berg;Cancer Chemother Pharmacol,1982

4. Vincristine in childhood leukaemia: No pharmacokinetic rationale for dose reduction in adolescents;Frost;Acta Paediatr,2003

5. Pharmacokinetics of vincristine in children and adolescents with acute lymphoblastic leukemia;Crom;J Pediatr,1994

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study;Pediatric Blood & Cancer;2024-07-02

2. Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products;Genes;2024-04-08

3. Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice;Drug Metabolism and Disposition;2023-12-08

4. Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs;Frontiers in Pharmacology;2023-11-17

5. Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy;Cancer Chemotherapy and Pharmacology;2023-08-23